During the past decade, Malopolskie Centrum Medyczne S.C. conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 46 clinical trials were completed, i.e. on average, 143.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 24 clinical trials were completed. i.e. 480% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Malopolskie Centrum Medyczne S.C." #1 sponsor was "Gilead Sciences" with 8 trials, followed by "Pfizer" with 7 trials sponsored, "Celgene" with 5 trials sponsored, "Ipsen" with 5 trials sponsored and "BeiGene" with 5 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Malopolskie Centrum Medyczne S.C." #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Malopolskie Centrum Medyczne S.C." are "Chronic Lymphocytic Leukemia" (4 trials), "Rheumatoid Arthritis" (4 trials), "Follicular Lymphoma" (3 trials), "Mantle Cell Lymphoma" (3 trials) and "Ankylosing Spondylitis" (2 trials). Many other conditions were trialed in "Malopolskie Centrum Medyczne S.C." in a lesser frequency.

Most popular intervention types in "Malopolskie Centrum Medyczne S.C." are "Drug" (63 trials), "Biological" (7 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "Rituximab" (11 trials), "Idelalisib" (8 trials), "Bendamustine" (5 trials) and "Botulinum toxin type A" (5 trials). Other intervention names were less common.

The vast majority of trials in "Malopolskie Centrum Medyczne S.C." are 66 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Malopolskie Centrum Medyczne S.C.". undefined are not yet recruiting, 4 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 39 completed trials in Malopolskie Centrum Medyczne S.C., undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Malopolskie Centrum Medyczne S.C., 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".